PACB is up 6.64% today. Volume is 9.56M vs a 30-day average of 16.05M (0.60x).
Pacific Biosciences of Californ is scheduled to report earnings Wed, Nov 4, 2026 · after close. Analysts expect EPS of $-0.15 on revenue of about $41.19M. Stocks often move sharply on earnings day.
The latest trading day saw Pacific Biosciences of California (PACB) settling at $2.06, representing a -3.74% change from its previous close.
Verily Pre will connect PacBio HiFi Sequencing with governed cloud analysis, multimodal health data and AI-ready research workflowsMENLO PARK, Calif. and DALLAS, Oct. 19, 2026 (GL…
PacBio (NASDAQ:PACB), developer of the world’s most advanced sequencing technologies, and Verily Health Inc., a healthcare data intelligence company, announced today a multi-year …
MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2026 finan…
PACB partners with TychoBio to harness AI and long-read RNA sequencing for rare disease therapies, aiming to improve drug efficacy and safety through advanced data models.